Kathy Allen

810 total citations
15 papers, 617 citations indexed

About

Kathy Allen is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Kathy Allen has authored 15 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pathology and Forensic Medicine, 7 papers in Oncology and 5 papers in Genetics. Recurrent topics in Kathy Allen's work include Cancer Risks and Factors (7 papers), Phytoestrogen effects and research (6 papers) and Estrogen and related hormone effects (5 papers). Kathy Allen is often cited by papers focused on Cancer Risks and Factors (7 papers), Phytoestrogen effects and research (6 papers) and Estrogen and related hormone effects (5 papers). Kathy Allen collaborates with scholars based in United States and Switzerland. Kathy Allen's co-authors include Nagi B. Kumar, Alan Cantor, Diane Riccardi, Charles E. Cox, Karen Besterman‐Dahan, Julio M. Pow‐Sang, Raoul Salup, Gary H. Lyman, Jeffrey P. Krischer and John D. Seigne and has published in prestigious journals such as Cancer, International Journal of Radiation Oncology*Biology*Physics and Neurosurgery.

In The Last Decade

Kathy Allen

15 papers receiving 590 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kathy Allen United States	13	226	198	132	125	104	15	617
Annika Bylund Sweden	8	185 0.8×	107 0.5×	108 0.8×	75 0.6×	100 1.0×	9	570
Diane Riccardi United States	10	219 1.0×	133 0.7×	76 0.6×	120 1.0×	78 0.8×	14	525
Bas A.J. Verhage Netherlands	20	128 0.6×	239 1.2×	227 1.7×	98 0.8×	104 1.0×	37	814
R K Severson United States	4	235 1.0×	151 0.8×	84 0.6×	104 0.8×	145 1.4×	8	606
Yoshie Nagata Japan	12	243 1.1×	141 0.7×	112 0.8×	74 0.6×	62 0.6×	14	580
James R. Marshall United States	2	148 0.7×	315 1.6×	64 0.5×	86 0.7×	139 1.3×	3	576
Shogen Matsushita Japan	13	279 1.2×	250 1.3×	111 0.8×	89 0.7×	48 0.5×	16	649
Jin Xiang China	12	96 0.4×	156 0.8×	194 1.5×	54 0.4×	73 0.7×	32	552
U. Peters United States	5	207 0.9×	91 0.5×	108 0.8×	88 0.7×	59 0.6×	5	559
Colinda C.J.M. Simons Netherlands	17	188 0.8×	301 1.5×	247 1.9×	63 0.5×	68 0.7×	38	694

Countries citing papers authored by Kathy Allen

Since Specialization

Citations

This map shows the geographic impact of Kathy Allen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Allen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Allen more than expected).

Fields of papers citing papers by Kathy Allen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Allen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Allen. The network helps show where Kathy Allen may publish in the future.

Co-authorship network of co-authors of Kathy Allen

This figure shows the co-authorship network connecting the top 25 collaborators of Kathy Allen. A scholar is included among the top collaborators of Kathy Allen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kathy Allen. Kathy Allen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

1.

Kumar, Nagi B., Loveleen Kang, Julio M. Pow‐Sang, et al.. (2010). Results of a randomized phase I dose-finding trial of several doses of isoflavones in men with localized prostate cancer: administration prior to radical prostatectomy.. PubMed. 8(1). 3–13. 26 indexed citations

2.

Kumar, Nagi B., Karen Besterman‐Dahan, Loveleen Kang, et al.. (2008). Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy. PubMed. 1. CMU.S718–CMU.S718. 36 indexed citations

3.

Kumar, Nagi B., Jeffrey P. Krischer, Kathy Allen, et al.. (2007). Safety of Purified Isoflavones in Men With Clinically Localized Prostate Cancer. Nutrition and Cancer. 59(2). 169–175. 18 indexed citations

4.

Kumar, Nagi B., Jeffrey P. Krischer, Kathy Allen, et al.. (2007). A Phase II Randomized, Placebo-Controlled Clinical Trial of Purified Isoflavones in Modulating Steroid Hormones in Men Diagnosed With Localized Prostate Cancer. Nutrition and Cancer. 59(2). 163–168. 40 indexed citations

5.

Kumar, Nagi B., et al.. (2005). A Case-Control Study Evaluating the Association of Purposeful Physical Activity, Body Fat Distribution, and Steroid Hormones on Premenopausal Breast Cancer Risk. The Breast Journal. 11(4). 266–272. 14 indexed citations

6.

Kumar, Nagi B., Kathy Allen, & Heather Bell. (2005). Perioperative Herbal Supplement Use in Cancer Patients: Potential Implications and Recommendations for Presurgical Screening. Cancer Control. 12(3). 149–157. 36 indexed citations

7.

Kumar, Nagi B., Alan Cantor, Kathy Allen, et al.. (2003). The specific role of isoflavones in reducing prostate cancer risk. The Prostate. 59(2). 141–147. 117 indexed citations

8.

Kumar, Nagi B., Alan Cantor, Kathy Allen, Diane Riccardi, & Charles E. Cox. (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 94(4). 1166–1174. 92 indexed citations

9.

Kumar, Nagi B., Alan Cantor, Kathy Allen, Diane Riccardi, & Charles E. Cox. (2002). The specific role of isoflavones on estrogen metabolism in premenopausal women. Cancer. 94(4). 1166–1174. 5 indexed citations

10.

Kumar, Nagi B., et al.. (2002). Use of Complementary/Integrative Nutritional Therapies during Cancer Treatment: Implications in Clinical Practice. Cancer Control. 9(3). 236–243. 29 indexed citations

11.

Kumar, Nagi B., Alan Cantor, Kathy Allen, & Charles E. Cox. (2000). Android obesity at diagnosis and breast carcinoma survival. Cancer. 88(12). 2751–2757. 59 indexed citations

12.

Vale, Fernando Ĺ., et al.. (1997). Pallidotomy: Lesion delivery and clinical outcome. Neurosurgery. 41(3). 739–739. 1 indexed citations

13.

Kumar, Nagi B., Kathy Allen, Alan Cantor, et al.. (1997). Weight gain associated with adjuvant tamoxifen therapy in stage I and II breast cancer: fact or artifact?. Breast Cancer Research and Treatment. 44(2). 135–143. 33 indexed citations

14.

Kumar, Nagi B., Gary H. Lyman, Kathy Allen, Charles E. Cox, & David V. Schapira. (1995). Timing of weight gain and breast cancer risk. Cancer. 76(2). 243–249. 45 indexed citations

15.

Kavanagh, Brian D., Mitchell S. Anscher, Kenneth A. Leopold, et al.. (1992). Patterns of failure following combined modality therapy for esophageal cancer, 1984–1990. International Journal of Radiation Oncology*Biology*Physics. 24(4). 633–642. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact